Search database
Filter
13
Text search: Kisanga O.
Featured
Language
Document type
No document type
10
Studies & Reports
1
Situation Updates
1
Strategic & Response Plan
1
Countries / Regions
Congo, Democratic Republic of
5
Tanzania
1
South Africa
1
Ukraine
1
Africa
1
Venezuela
1
Southern Africa
1
Russia
1
Authors & Publishers
Regional Network for Equity in Health in East and Southern Africa (EQUINET)
3
World Health Organization WHO
2
BMC Infectious Diseases
1
Direction de Lutte contre la Maladie, Ministère de la Santé Publique, République Démocratique du Congo
1
EngenderHealth
1
Kisanga O.
1
Mamdani M.
1
Ministère de la Santé Publique, Republique Démocratique du Congo
1
Nswilla A.
1
Programme Intégré de Santé de Reproduction et Familiale (PISRF)
1
R. Loewenson, M. Mamdani and others
1
Tilahun Tadesse, B., E. A. Ashley, S. Ongarello et al.
1
Todd G.
1
UN Office for the Coordination of Humanitarian Affairs
1
UNICEF, OMS
1
Васильева Ирина Анатольевна, Самойлова Анастасия Геннадьевна, Эргешов Атаджан Эргешович et al.
1
федеральное государственное бюджетное учреждение центральный научно-исследовательский институт туберкулеза российской академии медицинских наук, Американский международный союз здравоохранения
1
Publication Years
Category
Countries
8
Clinical Guidelines
2
Public Health
1
Women & Child Health
1
Key Resources
1
Toolboxes
TB
2
Ebola
1
AMR
1
COVID-19
1

A case study of the Essential Health Benefit in Tanzania mainland

Todd G.; Nswilla A.; Kisanga O.; Mamdani M. Regional Network for Equity in Health in east and southern Africa (EQUINET) (2017) C1
Regional Network for Equity in Health in east and southern Africa (EQUINET): Disussion Paper 109
This report describes the evolution of mainland Tanzania’s EHB; the motivations for developing the EHBs, the methods used to develop, define and cost them; how it is being disseminated, communicat ... more
Internationally, there is a growing concern over antimicro-bial resistance (AMR) which is currently estimated to ac-count for more than 700,000 deaths per year worldwide. If no appropriate measures are taken to halt its pro-gress, AMR will cost approximately 10 million lives andabout US$100 trillion ... more

Диагностика и лечение туберкулеза с множественной лекарственной устойчивостью возбудителя

Васильева Ирина Анатольевна, Самойлова Анастасия Геннадьевна, Эргешов Атаджан Эргешович et al. федеральное государственное бюджетное учреждение центральный научно-исследовательский институт туберкулеза российской академии медицинских наук, Американский международный союз здравоохранения (2012) C2
Cовершенствование теоретических знаний и практических навыков по вопросам диагностики и лечения туберкулеза с множественной лекарственной устойчивостью (МЛУ) ми ... more
Regional Network for Equity in Health in east and southern Africa (EQUINET): Disussion Paper 113
This report synthesises the learning across the full programme of work. It presents the methods used, the context and policy motivations for developing EHBs; how they are being defined, costed, di ... more
Un Plan humanitaire multisectoriel spécifique à la réponse COVID-19 a été développé en avril 2020 et constitue un Addendum au Plan de réponse humanitaire 2020 (PRH) afin d’intégrer l’impact de la pandémie de COVID-19 sur les besoins humanitaires existants et sur les activités des part ... more
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi ... more